Abstract:Periodontal diseases comprise mixed bacterial infections mainly caused by Gram‑negative anaerobic bacteria. Lipopolysaccharides (LPS) are important virulence factors and periodontal pathogens, which change local cytokine levels and promote osteoblast apoptosis, thereby leading to an imbalance in bone remodeling mechanisms and accelerating bone loss. Calcitonin gene‑related peptide (CGRP) is a vasoactive neuropeptide that is released from sensory nerves and has a positive effect on osteoblast proliferation and differentiation. In addition, this small molecule peptide is an important immune regulator in the inflammatory response. The aim of the present study was to assess the in vitro effects of CGRP on Porphyromonas gingivalis (Pg)LPS‑induced osteoblast apoptosis. Osteoblast cultures were stimulated either with various concentrations of PgLPS (0, 25, 50, 100, 500 and 1,000 ng/ml) for 48 h or with 500 ng/ml PgLPS for various lengths of time (0, 6, 12, 24, 48 and 72 h). The PgLPS‑stimulated cells were pretreated with different concentrations of CGRP (0, 1, 10, 100 and 1,000 nM) and cell viability and apoptotic rates were measured by Cell Counting kit‑8 assays and flow cytometry, respectively. CGRP, cleaved (c)‑Caspase‑8 and c‑Caspase‑3 protein expression levels were analyzed by western blotting. Changes in cytokine expression levels, which included tumor necrosis factor (TNF)‑α, interleukin (IL)‑1β, IL‑6, monocyte chemotactic protein (MCP)‑1 and MCP‑2, were measured by ELISA. PgLPS was demonstrated to inhibit osteoblast viability and promote apoptosis in a time‑ and concentration‑dependent manner. CGRP expression was revealed to reduce PgLPS‑induced cytostatic activity and apoptosis in osteoblasts. CGRP also suppressed the PgLPS‑induced release of TNF‑α and inhibited the activation of c‑Caspase‑3 and c‑Caspase‑8, thus preventing apoptosis in osteoblasts. CGRP may be an important neuropeptide in bone remodeling and may reduce osteoblast apoptosis in inflammatory conditions. These results may provide a solid foundation for CGRP to serve as a new target for the treatment of periodontitis.

CpG Oligodeoxynucleotides Inhibit the Proliferation and Osteoclastic Differentiation of RAW264.7 Cells

Autophagy Negative-Regulating Wnt Signaling Enhanced Inflammatory Osteoclastogenesis from Pre-OCs in Vitro

The Toll-like Receptor Ligand, CpG Oligodeoxynucleotides, Regulate Proliferation and Osteogenic Differentiation of Osteoblast

Cpg Oligonucleotides: Novel Regulators Of Osteoclast Differentiation

CPG OLIGONUCLEOTIDES REGULATE OSTEOCLAST DIFFERENTIATION

CpG Oligodeoxynucleotides Modulate the Osteoclastogenic Activity of Osteoblasts Via Toll-like Receptor 9*

Osteogenic CpG oligodeoxynucleotide, iSN40, inhibits osteoclastogenesis in a TLR9-dependent manner

CpG ODN/Mangiferin Dual Delivery through Calcium Alginate Hydrogels Inhibits Immune-Mediated Osteoclastogenesis and Promotes Alveolar Bone Regeneration in Mice

An Oligodeoxynucleotide with Promising Modulation Activity for the Proliferation and Activation of Osteoblast.

Lactobacillus rhamnosus inhibits osteoclast differentiation by suppressing the TLR2/NF-κB pathway

Osteoprotegerin Influences The Bone Resorption Activity Of Osteoclasts

An Oligodeoxynucleotide That Induces Differentiation of Bone Marrow Mesenchymal Stem Cells to Osteoblasts in Vitro and Reduces Alveolar Bone Loss in Rats with Periodontitis.

A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis

Effect of chondroitin sulfate modified polyethyleneimine on mediating oligodeoxynucleotide YW002 in the treatment of periodontitis

Effect of Porphyromonas Gingivalis Lipopolysaccharide on Innate Immune Responses in Bone-Marrow Derived Macrophages and Osteoclasts

Frontline Science: Characterization and Regulation of Osteoclast Precursors Following Chronic Porphyromonas Gingivalis Infection

Calcitonin gene‑related peptide reduces Porphyromonas gingivalis LPS‑induced TNF‑α release and apoptosis in osteoblasts

Chitooligosaccharide Inhibits RANKL-induced Osteoclastogenesis and Ligation-Induced Periodontitis by Suppressing MAPK/ C-Fos/nfatc1 Signaling.

A small molecule, odanacatib, inhibits inflammation and bone loss caused by endodontic disease

Activation of Cannabinoid Receptor CB2 Regulates LPS-induced Pro-Inflammatory Cytokine Production and Osteoclastogenic Gene Expression in Human Periodontal Ligament Cells

NF-κB Decoy ODN-Loaded Poly(Lactic-co-glycolic Acid) Nanospheres Inhibit Alveolar Ridge Resorption